Congenital Adrenal Hyperplasia Blogs 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.The Op-Ed: Off-Label Pregnancy Rx Needs More Regs
With all the talk of off-label promotion and commercial free speech, a vexing issue remains – patient safety. A case in point is the use of dexamethasone, which is sometimes given to pregnant women at risk of having a child with congenital adrenal hyperplasia. Prenatal dexamethasone cannot prevent a child being born with CAH, but it may reduce the odds a girl will be born sex atypical from having CAH. A recent paper in AJOG argued against the use because of safety concerns. We asked Alice Dreger, a professor of Clinical Medical Humanities & Bioethics at Northwestern University, to explain…
In a legal case...
Source: Pharmalot - February 27, 2013 Category: Pharma Commentators Authors: Ed Silverman Tags: Uncategorized Alice Dreger Dexamethasone Medical Ethics Off Label Promotion Source Type: blogs
